INTEC PARENT INC. - Daily - Technical analysis published on 07/22/2021 (GMT)
- 203
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
INTEC PARENT INC. Chart
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Slightly bullish
Technical indicators
83%
0%
17%
My opinion
Bullish above 3.95 USD
My targets
4.20 USD (+2.62%)
4.53 USD (+10.76%)
My analysis
The strong short-term increase for INTEC PHARMA reinforces the current slightly bullish trend. As long as the price remains above 3.95 USD, you could take advantage of this bullish acceleration. The first bullish objective is located at 4.20 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 4.53 USD as an objective. Crossing it would then enable buyers to target 5.96 USD. A return to 3.95 USD would be a sign of a possible correction of short-term bullish excesses. In this case, you could stay away while waiting for signals indicating a reversal of the trend.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
4.8
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by aba0550.
Additional analysis
Quotes
The INTEC PHARMA price is 4.09 USD. The price registered an increase of +12.98% on the session and was between 3.52 USD and 4.30 USD. This implies that the price is at +16.19% from its lowest and at -4.88% from its highest.3.52
4.30
4.09
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of INTEC PHARMA in Daily shows an overall slightly bullish trend. 53.57% of the signals given by moving averages are bullish. This slightly bullish trend could be reinforced by the strong bullish signals given by short-term moving averages. The Central Indicators market scanner is currently detecting a bullish signal that could impact this trend:
Bullish trend reversal : adaptative moving average 20
Type : Bullish
Timeframe : Daily
Technical indicators are strongly bullish, suggesting that the price increase should continue.
Central Indicators, the detector scanner for these technical indicators recently detected a signal:
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Weekly
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S2
S1
R1
R2
R3
Price
S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|
ProTrendLines | 2.29 | 3.37 | 4.09 | 4.53 | 5.96 | 7.85 |
Change (%) | -44.01% | -17.60% | - | +10.76% | +45.72% | +91.93% |
Change | -1.80 | -0.72 | - | +0.44 | +1.87 | +3.76 |
Level | Minor | Major | - | Major | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.82 | 3.07 | 3.35 | 3.60 | 3.88 | 4.13 | 4.41 |
Camarilla | 3.47 | 3.52 | 3.57 | 3.62 | 3.67 | 3.72 | 3.77 |
Woodie | 2.83 | 3.08 | 3.36 | 3.61 | 3.89 | 4.14 | 4.42 |
Fibonacci | 3.07 | 3.28 | 3.40 | 3.60 | 3.81 | 3.93 | 4.13 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.52 | 2.78 | 3.08 | 3.34 | 3.64 | 3.90 | 4.20 |
Camarilla | 3.22 | 3.27 | 3.32 | 3.37 | 3.42 | 3.47 | 3.52 |
Woodie | 2.53 | 2.79 | 3.09 | 3.35 | 3.65 | 3.91 | 4.21 |
Fibonacci | 2.78 | 3.00 | 3.13 | 3.34 | 3.56 | 3.69 | 3.90 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 1.03 | 2.16 | 2.82 | 3.95 | 4.61 | 5.74 | 6.40 |
Camarilla | 2.98 | 3.14 | 3.31 | 3.47 | 3.63 | 3.80 | 3.96 |
Woodie | 0.79 | 2.04 | 2.58 | 3.83 | 4.37 | 5.62 | 6.16 |
Fibonacci | 2.16 | 2.85 | 3.27 | 3.95 | 4.64 | 5.06 | 5.74 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
RSI (14): | 62.16 | |
MACD (12,26,9): | -0.0500 | |
Directional Movement: | 20.96 | |
AROON (14): | 71.43 | |
DEMA (21): | 3.40 | |
Parabolic SAR (0,02-0,02-0,2): | 3.02 | |
Elder Ray (13): | 0.33 | |
Super Trend (3,10): | 4.06 | |
Zig ZAG (10): | 3.97 | |
VORTEX (21): | 0.9400 | |
Stochastique (14,3,5): | 69.14 | |
TEMA (21): | 3.42 | |
Williams %R (14): | -17.43 | |
Chande Momentum Oscillator (20): | 0.56 | |
Repulse (5,40,3): | 15.5100 | |
ROCnROLL: | 1 | |
TRIX (15,9): | -0.5300 | |
Courbe Coppock: | 0.03 |
MA7: | 3.45 | |
MA20: | 3.40 | |
MA50: | 3.67 | |
MA100: | 3.95 | |
MAexp7: | 3.51 | |
MAexp20: | 3.51 | |
MAexp50: | 3.68 | |
MAexp100: | 3.92 | |
Price / MA7: | +18.55% | |
Price / MA20: | +20.29% | |
Price / MA50: | +11.44% | |
Price / MA100: | +3.54% | |
Price / MAexp7: | +16.52% | |
Price / MAexp20: | +16.52% | |
Price / MAexp50: | +11.14% | |
Price / MAexp100: | +4.34% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
The latest news and videos published on INTEC PHARMA at the time of the analysis were as follows:
- SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Intec Pharma Ltd. - NTEC
- SHAREHOLDER ALERT: WeissLaw LLP Investigates Intec Pharma Ltd.
- INTEC PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Intec Pharma Ltd. - NTEC
- Intec Pharma Ltd - NTEC Stock Chart Technical Analysis for 03-15-2021
- Intec Pharma and Decoy Biosystems Announce Merger Agreement
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis INTEC PARENT INC. - Daily